Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease
The British Association of Dermatology annual meeting sees the launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of moderate to severe atopic eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients. Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
generic viagra
HIVMA Supports Public Plan Option To Ensure Patients' Needs Are Met
As Congress drafts health care reform legislation, HIV clinicians urge lawmakers to include a public plan option to ensure affordable access to comprehensive care for HIV patients - nearly 30 percent of whom have no insurance. The HIV Medicine Association (HIVMA) believes that a public plan option can help offer everyone the chance to benefit from early and reliable access to lifesaving HIV care and treatment.
Zubni implantati
News of the day
Preserving Patient Access To Primary Care Act Of 2009 Endorsed By American College Of Physicians
The 128,000-member American College of Physicians (ACP) has endorsed the Preserving Patient Access to Primary Care Act of 2009 (H.R. 2350), introduced by Rep. Allyson Schwartz (D-PA). "Primary care is the best medicine for better health and lower costs," ACP noted, "and this is the best medicine for curing the growing crisis in primary care."
Oncology

Cosmetic Ear Surgery Has The Youngest Age Of Patients, Survey Finds

So many classic childhood movies (Dumbo) and sing-a-longs (Do your ears hang low? Do they wobble to and fro?) emphasize large and protruding ears. But it turns out that having protruding ears is often-times a humiliating feature for a teenager. According to the American Academy of Cosmetic Surgery"s 2008 Procedural Survey, 27.7% of otoplasties - a reshaping of the ear by placing small incisions behind the ear then reshaping or trimming the cartilage to define how and where the ear bends - are performed on those ages 13-19. Additionally, the survey found that otoplasty has the youngest mean age of both invasive and less invasive cosmetic procedures at 29. "While cosmetic surgery is not for all adolescents, there appears to be a trend in otoplasty for younger patients," states Dr. Patrick McMenamin, MD, President of the AACS. "The bottom line is that if the teen is of appropriate psychological and physical maturity, then the teen can reap the benefits of an early age otoplasty. In my experience, it is the youngster who comes in adamantly requesting the procedure." Generally, ears reach their full growth potential by age 6 which is drastically earlier than other parts of an adolescent body. In fact, it is preferred to have an otoplasty at a younger age because the cartilage is extremely flexible, thereby permitting greater ease of shaping and a better result. Sarah Massier American Academy of Cosmetic Surgery


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Copyright 2009